Parkinson's disease (PD) is a progressive neurodegenerative disorder primarily affecting the motor system. It's characterized by four cardinal symptoms: bradykinesia, resting tremor, rigidity, and postural instability. Understanding its pathophysiology, diagnosis, and management is essential for healthcare professionals to provide optimal patient care.
PD is primarily associated with the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to a reduction in striatal dopamine. This imbalance in the basal ganglia circuitry results in the characteristic motor symptoms. The presence of Lewy bodies, intracellular inclusions containing alpha-synuclein, is a pathological hallmark of PD.
Diagnosis of PD is clinical, based on history and physical examination. There are no definitive diagnostic tests. The presence of at least two of the four cardinal symptoms, with one being either resting tremor or bradykinesia, suggests PD. Neuroimaging can help exclude other causes of parkinsonism but is not routinely used in diagnosis.
Management of PD aims to improve quality of life by controlling symptoms. Pharmacological therapy, mainly dopaminergic medications, is the mainstay of treatment. Non-pharmacological interventions, including physiotherapy and occupational therapy, are also crucial. Deep brain stimulation may be considered in patients with severe motor fluctuations unresponsive to medication.
PD is a chronic, progressive disease. The rate of progression varies widely among individuals. While it is not fatal, complications can significantly affect quality of life and can be life-threatening. Regular follow-up and adjustment of management plans are crucial in maintaining optimal patient functioning and well-being.
Understanding Parkinson's disease, its pathophysiology, diagnosis, management, and prognosis, is vital for healthcare professionals. This knowledge enables the provision of comprehensive care to patients, improving their quality of life and managing the progression of this chronic, neurodegenerative disorder.
1.
Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?
2.
Should the UK introduce targeted prostate cancer screening? The case for and against
3.
Real-World EV Plus Pembro Success Seen in Urothelial Cancer
4.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
5.
Investigating the Relationship Between GERD and Anxiety/Depression.
1.
Building Physical Resilience in Chronic Blood Disorders
2.
Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control
3.
Artificial Intelligence for Spatial Tumor Evolution Reconstruction
4.
What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells
5.
Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
Understanding Risk Factors Associated With Common Cancers
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
5.
The Role of Hemoglobin in Maintaining Healthy Oxygen Levels
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation